Title 42 › Chapter CHAPTER 163— - RESEARCH AND DEVELOPMENT, COMPETITION, AND INNOVATION › Subchapter SUBCHAPTER IV— - BIOECONOMY RESEARCH AND DEVELOPMENT › § 19134
The agency co-chair must, after talking with the Office of Science and Technology Policy, set up an advisory committee on engineering biology research and development. The group must have at least 12 members from research and schools, industry, and nongovernmental groups who can give advice on the Initiative. The committee must review U.S. strength and investments in engineering biology worldwide; market barriers to turning lab work into products, methods, and tools; progress and any need to change the Initiative; how activities and funding are balanced; whether the interagency strategic plan keeps the United States a leader; and whether ethical, legal, environmental, safety, security, and other public concerns are being covered. No later than two years after August 9, 2022, and at least every five years after that, the committee must report its findings and recommendations to the President and to these congressional committees: House — Committee on Science, Space, and Technology; Committee on Energy and Commerce; Committee on Agriculture. Senate — Committee on Commerce, Science, and Transportation; Committee on Health, Education, Labor, and Pensions; Committee on Agriculture, Nutrition, and Forestry. Section 14 of the Federal Advisory Committee Act does not apply to this committee. The committee will end 10 years after August 9, 2022 (August 9, 2032).
Full Legal Text
The Public Health and Welfare — Source: USLM XML via OLRC
Legislative History
Reference
Citation
42 U.S.C. § 19134
Title 42 — The Public Health and Welfare
Last Updated
Apr 6, 2026
Release point: 119-73